Skip to main content
. 2022 Jan 18;38(4):272–281. doi: 10.1159/000520464

Table 2.

Summary table (stage I and II)

N (Range/%)
Patients, n 81
Sex
 Male 39
 Female 42
Mean age, years 68.3 (31–92)
BMI, Ø 28.6 (19.1–4.2)
ASA grade, n (%)
 I 1 (1.2)
 II 54 (66.7)
 III 25 (30.9)
 IV 1 (1.2)
Smoker status, n (%)
 Smoker 16 (19.8)
 Non-smoker 65 (80.2)
Type II diabetes, n (%)
 Yes 18 (22.2)
 No 63 (77.8)
Diagnosis, n (%)
 Benign 42 (51.9)
 Malignant 39 (48.1)
Surgical technique, n (%)
 Laparoscopic 39 (48.1)
 Open 42 (51.9)
Surgical procedure, n (%)
 Hernioplasty 21 (25.9)
 Right hemicolectomy 17 (21.0)
 Sigmoidectomy 14 (17.3)
 Rectum resection 6 (7.4)
 Rectosigmoidectomy 5 (6.2)
 Left hemicolectomy 5 (6.2)
 Ileostomy reversal 5 (6.2)
 Hartmann reversal procedure 2 (2.4)
 Liver resection 1 (1.2)
 Resection of transverse colon 1 (1.2)
 Subtotal colectomy 1 (1.2)
 Gastrectomy 1 (1.2)
 Reversal of a loop colostomy 1 (1.2)
 Open cholecystectomy 1 (1.2)
Contamination class, n (%)
 Class I (clean) 20 (24.7)
 Class II (clean-contaminated) 8 (9.9)
 Class III (contaminated) 53 (65.4)
Wound length, Ø cm 12.8
Post-op lenght of stay (Ø days) 8.4 (2–28 d)
Clavien-Dindo classification, n (%)
 Grade 2/Group I 8 (9.9)
 Grade 3a/Group II 8 (9.9)
 Grade 4/Group III 1 (1.2)
SSI according CDC criteria
 Study stage I + II 3 CDC grade 1 (superficial)
 Study stage I 0
 Study stage II 3 CDC grade 1 (superficial)

BMI, body mass index, ASA, American Society of Anaesthesiologists, CDC, Centre for Disease Control and Prevention/USA; SSIs, surgical site infection.